New Animal Drugs for Use in Animal Feeds; Chlortetracycline, 53966 [E6-15103]

Download as PDF 53966 Federal Register / Vol. 71, No. 177 / Wednesday, September 13, 2006 / Rules and Regulations the right to make a unilateral filing with FERC to modify this Agreement under any applicable provision of the Federal Power Act and FERC’s rules and regulations; provided that each party shall have the right to protest any such filing by the other Party and to participate fully in any proceeding before FERC in which such modifications may be considered. Nothing in this Agreement shall limit the rights of the parties or of FERC under sections 205 or 206 of the Federal Power Act and FERC’s rules and regulations, except to the extent that the parties otherwise agree as provided herein.’’ Magalie R. Salas, Secretary. [FR Doc. E6–15126 Filed 9–12–06; 8:45 am] BILLING CODE 6717–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 558 New Animal Drugs for Use in Animal Feeds; Chlortetracycline AGENCY: Food and Drug Administration, HHS. Final rule, technical amendment. rmajette on PROD1PC67 with RULES1 ACTION: SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for use of an approved Type A medicated article containing chlortetracycline to formulate a freechoice loose mineral Type C medicated feed for beef and nonlactating dairy cattle. DATES: This rule is effective September 13, 2006. FOR FURTHER INFORMATION CONTACT: Eric S. Dubbin, Center for Veterinary Medicine (HFV–126), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301–827–0232, email: eric.dubbin@fda.hhs.gov. SUPPLEMENTARY INFORMATION: Alpharma Inc., One Executive Dr., Fort Lee, NJ 07024, filed NADA 48–761 for use of AUREOMYCIN 90 Granular (chlortetracycline) Type A medicated article to formulate a free-choice loose mineral Type C medicated feed for beef and nonlactating dairy cattle as an aid in the control of active infection of anaplasmosis caused by Anaplasma VerDate Aug<31>2005 16:23 Sep 12, 2006 Jkt 208001 marginale susceptible to chlortetracycline. The supplemental NADA is approved as of July 28, 2006, and the regulations are amended in 21 CFR 558.128 to reflect the approval. The basis of approval is discussed in the freedom of information summary. In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday. The agency has determined under 21 CFR 25.33(a)(1) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required. This rule does not meet the definition of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because it is a rule of ‘‘particular applicability.’’ Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801–808. List of Subjects in 21 CFR Part 558 Animal drugs, Animal feeds. I Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows: Ingredient Percent Cottonseed Meal 10.00 Trace Mineral/Vitamin Premix1 Calcium Carbonate 3.80 Dried Cane Molasses 3.00 Potassium Chloride 2.00 Mineral Oil 2.00 Iron Oxide 0.50 Chlortetracycline Type A medicated article (90 gram/lb) International Feed No. 3.33 3.50 5–01– 625 6–01– 069 4–04– 695 6–03– 755 8–03– 123 6–02– 431 1Content of vitamin and trace mineral premixes may be varied. However, they should be comparable to those used for other freechoice feeds. Formulation modifications require FDA approval prior to marketing. Selenium must comply with 21 CFR 573.920. Ethylenediamine dihydroiodide (EDDI) should comply with FDA Compliance Policy Guides Sec. 651.100 (CPG 7125.18). (ii) Amount. 6,000 grams per ton. (iii) Indications for use. Beef and nonlactating dairy cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. (iv) Limitations. Feed continuously on a free-choice basis at a rate of 0.5 to 2.0 mg chlortetracycline per head per day. (v) Sponsor. See No. 046573 in § 510.600(c) of this chapter. * * * * * PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS 1. The authority citation for 21 CFR part 558 continues to read as follows: Dated: August 30, 2006. Steven D. Vaughn, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. E6–15103 Filed 9–12–06; 8:45 am] BILLING CODE 4160–01–S I Authority: 21 U.S.C. 360b, 371. 2. In § 558.128, redesignate paragraph (e)(6) as paragraph (e)(7); and add new paragraph (e)(6) to read as follows: DEPARTMENT OF THE TREASURY § 558.128 26 CFR Part 54 I Chlortetracycline. * * * * * (e) * * * (6) It is used as a free-choice, loose mineral Type C feed as follows: (i) Specifications. Ingredient Percent Dicalcium Phosphate 46.20 Sodium Chloride (Salt) 15.00 Magnesium Oxide 10.67 PO 00000 Frm 00004 Fmt 4700 Sfmt 4700 International Feed No. 6–26– 335 6–04– 152 6–02– 756 Internal Revenue Service [TD 9277] RIN 1545–BE30 Employer Comparable Contributions to Health Savings Accounts Under Section 4980G; Correction Internal Revenue Service (IRS), Treasury. ACTION: Correcting amendment. AGENCY: SUMMARY: This document contains a correction to final regulations (TD 9277) that were published in the Federal E:\FR\FM\13SER1.SGM 13SER1

Agencies

[Federal Register Volume 71, Number 177 (Wednesday, September 13, 2006)]
[Rules and Regulations]
[Page 53966]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-15103]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 558


New Animal Drugs for Use in Animal Feeds; Chlortetracycline

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule, technical amendment.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect approval of a supplemental new animal drug 
application (NADA) filed by Alpharma Inc. The supplemental NADA 
provides for use of an approved Type A medicated article containing 
chlortetracycline to formulate a free-choice loose mineral Type C 
medicated feed for beef and nonlactating dairy cattle.

DATES: This rule is effective September 13, 2006.

FOR FURTHER INFORMATION CONTACT: Eric S. Dubbin, Center for Veterinary 
Medicine (HFV-126), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 301-827-0232, e-mail: eric.dubbin@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Alpharma Inc., One Executive Dr., Fort Lee, 
NJ 07024, filed NADA 48-761 for use of AUREOMYCIN 90 Granular 
(chlortetracycline) Type A medicated article to formulate a free-choice 
loose mineral Type C medicated feed for beef and nonlactating dairy 
cattle as an aid in the control of active infection of anaplasmosis 
caused by Anaplasma marginale susceptible to chlortetracycline. The 
supplemental NADA is approved as of July 28, 2006, and the regulations 
are amended in 21 CFR 558.128 to reflect the approval. The basis of 
approval is discussed in the freedom of information summary.
    In accordance with the freedom of information provisions of 21 CFR 
part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and 
effectiveness data and information submitted to support approval of 
this application may be seen in the Division of Dockets Management 
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
    The agency has determined under 21 CFR 25.33(a)(1) that this action 
is of a type that does not individually or cumulatively have a 
significant effect on the human environment. Therefore, neither an 
environmental assessment nor an environmental impact statement is 
required.
    This rule does not meet the definition of ``rule'' in 5 U.S.C. 
804(3)(A) because it is a rule of ``particular applicability.'' 
Therefore, it is not subject to the congressional review requirements 
in 5 U.S.C. 801-808.

List of Subjects in 21 CFR Part 558

    Animal drugs, Animal feeds.

0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is 
amended as follows:

PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

0
1. The authority citation for 21 CFR part 558 continues to read as 
follows:

    Authority: 21 U.S.C. 360b, 371.

0
2. In Sec.  558.128, redesignate paragraph (e)(6) as paragraph (e)(7); 
and add new paragraph (e)(6) to read as follows:


Sec.  558.128  Chlortetracycline.

* * * * *
    (e) * * *
    (6) It is used as a free-choice, loose mineral Type C feed as 
follows:
    (i) Specifications.

------------------------------------------------------------------------
         Ingredient                Percent        International Feed No.
------------------------------------------------------------------------
Dicalcium Phosphate          46.20               6-26-335
Sodium Chloride (Salt)       15.00               6-04-152
Magnesium Oxide              10.67               6-02-756
Cottonseed Meal              10.00               5-01-625
Trace Mineral/Vitamin        3.80                .......................
 Premix\1\
Calcium Carbonate            3.50                6-01-069
Dried Cane Molasses          3.00                4-04-695
Potassium Chloride           2.00                6-03-755
Mineral Oil                  2.00                8-03-123
Iron Oxide                   0.50                6-02-431
Chlortetracycline Type A     3.33                .......................
 medicated article (90 gram/
 lb)
------------------------------------------------------------------------
\1\Content of vitamin and trace mineral premixes may be varied. However,
  they should be comparable to those used for other free-choice feeds.
  Formulation modifications require FDA approval prior to marketing.
  Selenium must comply with 21 CFR 573.920. Ethylenediamine
  dihydroiodide (EDDI) should comply with FDA Compliance Policy Guides
  Sec. 651.100 (CPG 7125.18).

    (ii) Amount. 6,000 grams per ton.
    (iii) Indications for use. Beef and nonlactating dairy cattle: As 
an aid in the control of active infection of anaplasmosis caused by 
Anaplasma marginale susceptible to chlortetracycline.
    (iv) Limitations. Feed continuously on a free-choice basis at a 
rate of 0.5 to 2.0 mg chlortetracycline per head per day.
    (v) Sponsor. See No. 046573 in Sec.  510.600(c) of this chapter.
* * * * *

    Dated: August 30, 2006.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary 
Medicine.
[FR Doc. E6-15103 Filed 9-12-06; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.